In multiple sclerosis (characterized by up-regulation of pro-inflammatory cytokines), different anti-inflammatory agents (such as interferon beta (IFNβ) and glatiramer acetate) are known to ameliorate white matter damage [29]. Here, IFNB1 is linked to multiple sclerosis.